Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Magnetic-Competition-Induced Colossal Magnetoresistance in n-Type HgCr_{2}Se_{4} under High Pressure.

Sun JP, Jiao YY, Yi CJ, Dissanayake SE, Matsuda M, Uwatoko Y, Shi YG, Li YQ, Fang Z, Cheng JG.

Phys Rev Lett. 2019 Jul 26;123(4):047201. doi: 10.1103/PhysRevLett.123.047201.

PMID:
31491259
2.

An evaluation of wrong-way crashes from highway ramps in Kansas, USA.

Fitzsimmons EJ, Cunningham Iv JR, Dissanayake S, Liang J.

Int J Inj Contr Saf Promot. 2019 Sep;26(3):233-241. doi: 10.1080/17457300.2019.1625412. Epub 2019 Jun 14.

PMID:
31195895
3.

Development of cubic anvil type high pressure apparatus for neutron diffraction.

Dissanayake SE, Matsuda M, Munakata K, Kagi H, Gouchi J, Uwatoko Y.

J Phys Condens Matter. 2019 Sep 25;31(38):384001. doi: 10.1088/1361-648X/ab2688. Epub 2019 Jun 3.

PMID:
31158819
4.

Calibration of highway safety manual predictive models for Kansas freeway segments.

Matarage IC, Dissanayake S.

Int J Inj Contr Saf Promot. 2019 Sep;26(3):251-259. doi: 10.1080/17457300.2019.1621351. Epub 2019 Jun 3.

PMID:
31156032
5.

Impact of a local, coastal community based management regime when defining marine protected areas: Empirical results from a study in Okinawa, Japan.

Shah P, Dissanayake STM, Fujita Y, Nunes PALD.

PLoS One. 2019 Mar 8;14(3):e0213354. doi: 10.1371/journal.pone.0213354. eCollection 2019.

6.

Next-generation diamond cell and applications to single-crystal neutron diffraction.

Haberl B, Dissanayake S, Wu Y, Myles DAA, Dos Santos AM, Loguillo M, Rucker GM, Armitage DP, Cochran M, Andrews KM, Hoffmann C, Cao H, Matsuda M, Meilleur F, Ye F, Molaison JJ, Boehler R.

Rev Sci Instrum. 2018 Sep;89(9):092902. doi: 10.1063/1.5031454.

PMID:
30278728
7.

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer.

Cho S, Zammarchi F, Williams DG, Havenith CEG, Monks NR, Tyrer P, D'Hooge F, Fleming R, Vashisht K, Dimasi N, Bertelli F, Corbett S, Adams L, Reinert HW, Dissanayake S, Britten CE, King W, Dacosta K, Tammali R, Schifferli K, Strout P, Korade M 3rd, Masson Hinrichs MJ, Chivers S, Corey E, Liu H, Kim S, Bander NH, Howard PW, Hartley JA, Coats S, Tice DA, Herbst R, van Berkel PH.

Mol Cancer Ther. 2018 Oct;17(10):2176-2186. doi: 10.1158/1535-7163.MCT-17-0982. Epub 2018 Jul 31.

8.

Forward-Projected Model-Based Iterative Reconstruction in Screening Low-Dose Chest CT: Comparison With Adaptive Iterative Dose Reduction 3D.

Hassani C, Ronco A, Prosper AE, Dissanayake S, Cen SY, Lee C.

AJR Am J Roentgenol. 2018 Sep;211(3):548-556. doi: 10.2214/AJR.17.19245. Epub 2018 Jul 24.

PMID:
30040468
9.

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.

Płoszczuk A, Bosheva M, Spooner K, McIver T, Dissanayake S.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618777924. doi: 10.1177/1753466618777924.

10.

Rapid chemical de-N-glycosylation and derivatization for liquid chromatography of immunoglobulin N-linked glycans.

Kameyama A, Dissanayake SK, Thet Tin WW.

PLoS One. 2018 May 3;13(5):e0196800. doi: 10.1371/journal.pone.0196800. eCollection 2018.

11.

A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.

Dissanayake S, Suggett J.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817751346. doi: 10.1177/1753465817751346. Review.

12.

Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.

Pek SLT, Dissanayake S, Fong JCW, Lin MX, Chan EZL, Tang JI, Lee CW, Ong HY, Sum CF, Lim SC, Tavintharan S.

Atherosclerosis. 2018 Feb;269:106-116. doi: 10.1016/j.atherosclerosis.2017.12.028. Epub 2017 Dec 27.

PMID:
29353225
13.

A Pilot Study of the Normative Range of Overnight Urinary Free Cortisol Corrected for Creatinine in Children.

Wolthers OD, Mersmann S, Dissanayake S.

Clin Drug Investig. 2018 Apr;38(4):313-318. doi: 10.1007/s40261-017-0609-x.

PMID:
29256049
14.

An analysis of escalator-related injuries in metro stations in China, 2013-2015.

Xing Y, Dissanayake S, Lu J, Long S, Lou Y.

Accid Anal Prev. 2019 Jan;122:332-341. doi: 10.1016/j.aap.2017.10.007. Epub 2017 Nov 1.

PMID:
29078983
15.

Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.

Dissanayake S, Nagel M, Falaschetti E, Suggett J.

Pulm Pharmacol Ther. 2018 Feb;48:179-184. doi: 10.1016/j.pupt.2017.10.005. Epub 2017 Oct 10.

PMID:
29024795
16.

Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.

Wolthers OD, Moore A, Mersmann S, Dissanayake S.

J Aerosol Med Pulm Drug Deliv. 2017 Oct;30(5):373-380. doi: 10.1089/jamp.2016.1335. Epub 2017 May 16.

PMID:
28510491
17.

Nephrotoxicity-induced proteinuria increases biomarker diagnostic thresholds in acute kidney injury.

Mohamed F, Buckley NA, Pickering JW, Wunnapuk K, Dissanayake S, Chathuranga U, Gawarammana I, Jayamanne S, Endre ZH.

BMC Nephrol. 2017 Apr 3;18(1):122. doi: 10.1186/s12882-017-0532-7.

18.

Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.

Dissanayake S, Denny WA, Gamage S, Sarojini V.

J Control Release. 2017 Mar 28;250:62-76. doi: 10.1016/j.jconrel.2017.02.006. Epub 2017 Feb 4. Review.

PMID:
28167286
19.

Calcifying Fibrous Pseudotumor of the Posterior Mediastinum With Encapsulation of the Thoracic Duct.

Dissanayake SN, Hagen J, Fedenko A, Lee C.

Ann Thorac Surg. 2016 Jul;102(1):e39-40. doi: 10.1016/j.athoracsur.2015.12.041.

PMID:
27343527
20.

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.

Papi A, Mansur AH, Pertseva T, Kaiser K, McIver T, Grothe B, Dissanayake S.

J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):346-61. doi: 10.1089/jamp.2015.1255. Epub 2016 Apr 22.

21.

A dynamic simulation/optimization model for scheduling restoration of degraded military training lands.

Önal H, Woodford P, Tweddale SA, Westervelt JD, Chen M, Dissanayake ST, Pitois G.

J Environ Manage. 2016 Apr 15;171:144-57. doi: 10.1016/j.jenvman.2016.02.005. Epub 2016 Feb 16.

PMID:
26895721
22.

Orbital Glass State of the Nearly Metallic Spinel Cobalt Vanadate.

Koborinai R, Dissanayake SE, Reehuis M, Matsuda M, Kajita T, Kuwahara H, Lee SH, Katsufuji T.

Phys Rev Lett. 2016 Jan 22;116(3):037201. doi: 10.1103/PhysRevLett.116.037201. Epub 2016 Jan 19.

PMID:
26849610
23.

Large-Scale and Controllable Synthesis of Graphene Quantum Dots from Rice Husk Biomass: A Comprehensive Utilization Strategy.

Wang Z, Yu J, Zhang X, Li N, Liu B, Li Y, Wang Y, Wang W, Li Y, Zhang L, Dissanayake S, Suib SL, Sun L.

ACS Appl Mater Interfaces. 2016 Jan 20;8(2):1434-9. doi: 10.1021/acsami.5b10660. Epub 2016 Jan 7.

PMID:
26710249
24.

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.

Papi A, Jones PW, Dalvi PS, McAulay K, McIver T, Dissanayake S.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 9;10:2431-8. doi: 10.2147/COPD.S93375. eCollection 2015.

25.

An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.

Dissanayake S, Jain M, Grothe B, McIver T, Papi A.

Pulm Pharmacol Ther. 2015 Dec;35:19-27. doi: 10.1016/j.pupt.2015.10.001. Epub 2015 Nov 10.

26.

Radio-guided occult lesion localisation using iodine 125 Seeds "ROLLIS" to guide surgical removal of an impalpable posterior chest wall melanoma metastasis.

Dissanayake S, Dissanayake D, Taylor DB.

J Med Radiat Sci. 2015 Sep;62(3):230-3. doi: 10.1002/jmrs.125. Epub 2015 Sep 3.

27.

Spin jam induced by quantum fluctuations in a frustrated magnet.

Yang J, Samarakoon A, Dissanayake S, Ueda H, Klich I, Iida K, Pajerowski D, Butch NP, Huang Q, Copley JR, Lee SH.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11519-23. doi: 10.1073/pnas.1503126112. Epub 2015 Aug 31.

28.

Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products.

Hendeles L, Daley-Yates PT, Hermann R, De Backer J, Dissanayake S, Horhota ST.

AAPS J. 2015 May;17(3):758-68. doi: 10.1208/s12248-015-9735-7. Epub 2015 Feb 26.

29.

Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.

Dissanayake SB.

AAPS J. 2015 May;17(3):754-7. doi: 10.1208/s12248-015-9734-8. Epub 2015 Feb 25.

30.

Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysis.

Papi A, Price D, Sastre J, Kaiser K, Lomax M, McIver T, Dissanayake S.

Respir Med. 2015 Feb;109(2):208-17. doi: 10.1016/j.rmed.2014.10.019. Epub 2014 Dec 3.

31.

Learning accurate and interpretable models based on regularized random forests regression.

Liu S, Dissanayake S, Patel S, Dang X, Mlsna T, Chen Y, Wilkins D.

BMC Syst Biol. 2014;8 Suppl 3:S5. doi: 10.1186/1752-0509-8-S3-S5. Epub 2014 Oct 22.

32.

Gender differences of young drivers on injury severity outcome of highway crashes.

Amarasingha N, Dissanayake S.

J Safety Res. 2014 Jun;49:113-20. doi: 10.1016/j.jsr.2014.03.004. Epub 2014 Apr 24.

33.

Computed tomography angiography of lower extremities in the emergency room for evaluation of patients with gunshot wounds.

Adibi A, Krishnam MS, Dissanayake S, Plotnik AN, Mohajer K, Arellano C, Ruehm SG.

Eur Radiol. 2014 Jul;24(7):1586-93. doi: 10.1007/s00330-014-3174-1. Epub 2014 May 8.

PMID:
24804632
34.

Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial.

Pertseva T, Dissanayake S, Kaiser K.

Curr Med Res Opin. 2013 Oct;29(10):1357-69. doi: 10.1185/03007995.2013.825592. Epub 2013 Aug 20.

PMID:
23865726
35.

Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry.

Liyanage A, Lekamwasam S, Dissanayake SP, Munidasa D.

Lupus. 2013 Aug;22(9):972-6. doi: 10.1177/0961203313496338. Epub 2013 Jul 16.

PMID:
23861026
36.

Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.

Dissanayake S, Grothe B, Kaiser K.

Respir Med. 2012 Dec;106 Suppl 1:S20-8. doi: 10.1016/S0954-6111(12)70006-9. Review.

37.

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.

Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S.

J Asthma. 2012 Dec;49(10):1060-70. doi: 10.3109/02770903.2012.719253. Epub 2012 Oct 26.

PMID:
23102189
38.

Novel extraction of volatile biomarkers from canine breath for gas chromatography-mass spectrometry.

Dissanayake S, Lathan P, Mlsna T.

J Breath Res. 2012 Dec;6(4):041001. doi: 10.1088/1752-7155/6/4/041001. Epub 2012 Sep 18.

PMID:
22989995
39.

Opportunistic pathogens in diabetic foot lesions.

Bowling FL, Dissanayake SU, Jude EB.

Curr Diabetes Rev. 2012 May;8(3):195-9. Review.

PMID:
22497655
40.

The diabetic Charcot foot.

Dissanayake SU, Bowling FL, Jude EB.

Curr Diabetes Rev. 2012 May;8(3):191-4. Review.

PMID:
22429012
41.

Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report.

Evans C, Cipolla D, Chesworth T, Agurell E, Ahrens R, Conner D, Dissanayake S, Dolovich M, Doub W, Fuglsang A, García Arieta A, Golden M, Hermann R, Hochhaus G, Holmes S, Lafferty P, Lyapustina S, Nair P, O'Connor D, Parkins D, Peterson I, Reisner C, Sandell D, Singh GJ, Weda M, Watson P.

J Aerosol Med Pulm Drug Deliv. 2012 Jun;25(3):117-39. doi: 10.1089/jamp.2011.0968. Epub 2012 Mar 13.

PMID:
22413806
42.

Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Soran H, France MW, Kwok S, Dissanayake S, Charlton-Menys V, Younis NN, Durrington PN.

Ann Clin Biochem. 2011 Nov;48(Pt 6):566-71. doi: 10.1258/acb.2011.010277. Epub 2011 Oct 17.

PMID:
22006975
43.

The biological effect of cyanoacrylate-combined calcium phosphate in rabbit calvarial defects.

Chang YY, Dissanayake S, Yun JH, Jung UW, Kim CS, Park KJ, Chai JK, Choi SH.

J Periodontal Implant Sci. 2011 Jun;41(3):123-30. doi: 10.5051/jpis.2011.41.3.123. Epub 2011 Jun 30.

44.

aeGEPUCI: a database of gene expression in the dengue vector mosquito, Aedes aegypti.

Dissanayake SN, Ribeiro JM, Wang MH, Dunn WA, Yan G, James AA, Marinotti O.

BMC Res Notes. 2010 Oct 4;3:248. doi: 10.1186/1756-0500-3-248.

45.

Evaluation of vitrification for cryopreservation of teeth.

Dissanayake SC, Che ZM, Choi SH, Lee SJ, Kim J.

J Periodontal Implant Sci. 2010 Jun;40(3):111-8. doi: 10.5051/jpis.2010.40.3.111. Epub 2010 Jun 25.

46.

Assessing the bioequivalence of analogues of endogenous substances ('endogenous drugs'): considerations to optimize study design.

Dissanayake S.

Br J Clin Pharmacol. 2010 Mar;69(3):238-44. doi: 10.1111/j.1365-2125.2009.03585.x. Review.

47.

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.

O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT.

Oncogene. 2010 Jan 7;29(1):34-44. doi: 10.1038/onc.2009.305. Epub 2009 Oct 5.

48.

The effect of milrinone on platelet activation as determined by TEG platelet mapping.

Wesley MC, McGowan FX, Castro RA, Dissanayake S, Zurakowski D, Dinardo JA.

Anesth Analg. 2009 May;108(5):1425-9. doi: 10.1213/ane.0b013e3181981fbe.

PMID:
19372315
49.

Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma.

Dissanayake SK, Weeraratna AT.

Methods Mol Biol. 2008;468:157-72. doi: 10.1007/978-1-59745-249-6_12.

50.

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.

Dissanayake SK, Olkhanud PB, O'Connell MP, Carter A, French AD, Camilli TC, Emeche CD, Hewitt KJ, Rosenthal DT, Leotlela PD, Wade MS, Yang SW, Brant L, Nickoloff BJ, Messina JL, Biragyn A, Hoek KS, Taub DD, Longo DL, Sondak VK, Hewitt SM, Weeraratna AT.

Cancer Res. 2008 Dec 15;68(24):10205-14. doi: 10.1158/0008-5472.CAN-08-2149.

Supplemental Content

Loading ...
Support Center